Cohen Yuval Insider Trading Activity

Average Profitability
10.48%
Insider Buys Quantity
25
Insider Buys Sum
$149,114.53
Insider Sells Quantity
4
Insider Sells Sum
$1.17M

Insider Activity of Cohen Yuval

According to the SEC Form 4 filings, Cohen Yuval, being in a position of

  1. Chief Executive Officer at Corbus Pharmaceuticals Holdings, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 30871 share for $279,348,
    over all time since 2014-12-03, has bought 57200 shares for $149,115, and sold 61763 shares for $1.45M.

Biography of Cohen Yuval

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$279,3482100

Comparison of Insiders on Amount of Buys and Sells

2026-08-07SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
17,000
0.0868%
$10.08$171,396-28.61%
2026-02-13SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
13,871
0.1139%
$7.78$107,952+18.78%
2025-02-14SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
7,134
0.0541%
$8.76$62,465-0.76%
2024-06-18SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
9,501
0.1849%
$42.24$401,294-67.39%
2024-06-17SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,770
0.0375%
$46.02$81,456-66.78%
2024-06-14SaleCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
12,487
0.2886%
$50.17$626,425-69.9%
2022-08-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
3,800
0.0005%
$0.26$1,003-23.53%
2022-05-16PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
10,500
0.0012%
$0.25$2,625-34.56%
2022-03-09PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
8,600
0.0015%
$0.37$3,182-44.14%
2020-11-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
4,240
0.0024%
$1.21$5,126+24.59%
2020-03-17PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
4,300
0.0069%
$3.49$15,007-30.88%
2019-11-12PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,430
0.0028%
$4.26$6,092+33.95%
2019-08-12PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,175
0.0033%
$6.06$7,116-6%
2019-05-13PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
995
0.0032%
$6.99$6,955-20.56%
2019-03-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,530
0.0046%
$6.49$9,930-14.71%
2018-05-15PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,725
0.0046%
$5.85$10,091+5.24%
2018-03-14PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,160
0.0037%
$6.88$7,987-8.82%
2017-11-10PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,000
0.0033%
$7.17$7,169-8.97%
2017-08-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
1,695
0.0047%
$6.00$10,170+9.24%
2017-05-11PurchaseCorbus Pharmaceuticals Holdings, Inc.
CRBP
Chief Executive Officer
3,250
0.009%
$6.01$19,539+10.57%
Total: 31
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.